GSE196594
Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks [siZBED2_siFOXA1]
RNA-seq Series of bladder carcinoma cell lines RT112 and SCaBER treated by siZBED2 and FOXA1. Overall design: RT112 and SCaBER bladder cancer cell lines were treated with siRNA against ZBED2 and FOXA1.